Visualising the Cross-Level Relationships between Pathological and Physiological Processes and Gene Expression: Analyses of Haematological Diseases

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Ono, Masahiro ^a   Tanaka, Reiko J ^b   Kano, Manabu ^c   Sugiman, Toshio ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; ECOLOGY; GENE CONTROL; GENE EXPRESSION; GENETIC TRAIT; HEMATOLOGIC DISEASE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HIGH RISK PATIENT; HUMAN; LEUKEMIA; MEGAKARYOCYTE ERYTHROID PROGENITOR; MICROARRAY ANALYSIS; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PHYSIOLOGICAL PROCESS; PROGNOSIS; SOCIOLOGY; TRANSCRIPTOMICS;

ALGORITHMS; ANTIGENS, CD34; CELL DIFFERENTIATION; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOLOGIC DISEASES; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; MYELODYSPLASTIC SYNDROMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; STEM CELLS; TRANSCRIPTOME;

EID: 84871744843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053544     Document Type: Article

References (64)

1. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217-26.
2. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-6.
3. Greenberg SA, Higgs BW, Morehouse C, Walsh RJ, Won Kong S, et al. (2012) Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes Immun 13: 207-13.
4. Symmans WF, Hatzis C, Sotiriou C, Andre F, Peintinger F, et al. (2010) Genomic index of sensitivity to endocrine therapy for breast cancer. J Clin Oncol 28: 4111-9.
5. Tanaka RJ, Ono M, Harrington HA, (2011) Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity. PLoS One 6: e19895.
6. Sandberg R, Ernberg I, (2005) Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (tsi). Proceedings of the National Academy of Sciences of the United States of America 102: 2052-2057.
7. Koury M, Mahmud N, Rhodes M (2008) Wintrobe's Clinical Hematology, Lippincott Williams & Wilkins, chapter Origin and Development of Blood Cells. 12 edition.
8. Larsson O, Wennmalm K, Sandberg R, (2006) Comparative microarray analysis. OMICS 10: 381-97.
9. Greenacre M (2008) Correspondence Analysis in Practice. London: Chapman & Hall/CRC, 2nd edition.
10. Tzeng J, Lu H, Li WH, (2008) Multidimensional scaling for large genomic data sets. BMC Bioinformatics 9: 179.
11. Wang HW, Trotter MWB, Lagos D, Bourboulia D, Henderson S, et al. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in kaposi sarcoma. Nat Genet 36: 687-693.
12. Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, et al. (2010) Molecular signatures to improve diagnosis in peripheral t-cell lymphoma and prognostication in angioimmunoblastic t-cell lymphoma. Blood 115: 1026-1036.
13. Kishino H, Waddell PJ, (2000) Correspondence analysis of genes and tissue types and finding genetic links from microarray data. Genome Inform Ser Workshop Genome Inform 11: 83-95.
14. Fellenberg K, Hauser NC, Brors B, Neutzner A, Hoheisel JD, et al. (2001) Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A 98: 10781-6.
15. Baty F, Facompre M, Wiegand J, Schwager J, Brutsche MH, (2006) Analysis with respect to instrumental variables for the exploration of microarray data structures. BMC Bioinformatics 7: 422.
16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, et al. (1976) Proposals for the classification of the acute leukaemias. french-american-british (fab) co-operative group. Br J Haematol 33: 451-8.
17. Griffin JD, Todd R F, Ritz J, Nadler LM, Canellos GP, et al. (1983) Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 61: 85-91.
18. Szczepanski T, van der Velden VH, van Dongen JJ, (2003) Classification systems for acute and chronic leukaemias. Best Pract Res Clin Haematol 16: 561-82.
19. Sell S, (2005) Leukemia: stem cells, maturation arrest, and differentiation therapy. Stem Cell Rev 1: 197-205.
20. Shih AH, Levine RL, (2011) Molecular biology of myelodysplastic syndromes. Semin Oncol 38: 613-20.
21. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-88.
22. Mills KI, Kohlmann A, Williams PM, Wieczorek L, Liu WM, et al. (2009) Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of aml transformation of myelodysplastic syndrome. Blood 114: 1063-72.
23. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, et al. (2009) The 2008 revision of the world health organization (who) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114: 937-51.
24. Cazzola M, (2011) Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Haematologica 96: 349-52.
25. Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, et al. (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to who criteria: a basis for clinical decision making. J Clin Oncol 23: 7594-603.
26. Wouters BJ, Lowenberg B, Delwel R, (2009) A decade of genome-wide gene expression profiling in acute myeloid leukemia: ashback and prospects. Blood 113: 291-8.
27. Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, et al. (2001) Signatures of the immune response. Immunity 15: 375-85.
28. Balgobind BV, Van den Heuvel-Eibrink MM, De Menezes RX, Reinhardt D, Hollink IH, et al. (2011) Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Haematologica 96: 221-30.
29. Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, et al. (2010) Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the international microarray innovations in leukemia study group. J Clin Oncol 28: 2529-37.
30. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, et al. (2011) Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144: 296-309.
31. Chiorazzi N, Ferrarini M, (2011) Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 117: 1781-91.
32. Cox CV, Blair A, (2005) A primitive cell origin for b-cell precursor all? Stem Cell Rev 1: 189-96.
33. Faderl S, Jeha S, Kantarjian HM, (2003) The biology and therapy of adult acute lymphoblastic leukemia. Cancer 98: 1337-54.
34. Lanasa MC, Weinberg JB, (2011) Immunoglobulin class switch recombination in chronic lymphocytic leukemia. Leuk Lymphoma 52: 1398-400.
35. Burkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, et al. (2007) Overexpression of the cxcr5 chemokine receptor, and its ligand, cxcl13 in b-cell chronic lymphocytic leukemia. Blood 110: 3316-25.
36. Fournier S, Delespesse G, Rubio M, Biron G, (1992) SarfatiM (1992) Cd23 antigen regulation and signalling in chronic lymphocytic leukemia. J Clin Invest 89: 1312-21.
37. Hubmann R, Duchler M, Schnabl S, Hilgarth M, Demirtas D, et al. (2010) Notch2 links protein kinase c delta to the expression of cd23 in chronic lymphocytic leukaemia (cll) cells. Br J Haematol 148: 868-78.
38. Miura Y, Shimazu R, Miyake K, Akashi S, Ogata H, et al. (1998) Rp105 is associated with md-1 and transmits an activation signal in human b cells. Blood 92: 2815-22.
39. Porakishvili N, Memon A, Vispute K, Kulikova N, Clark EA, et al. (2011) Cd180 functions in activation, survival and cycling of b chronic lymphocytic leukaemia cells. Br J Haematol 153: 486-98.
40. Anderson MK, (2006) At the crossroads: diverse roles of early thymocyte transcriptional regulators. Immunol Rev 209: 191-211.
41. Blobel GA, (2000) Creb-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95: 745-55.
42. Hart SM, Foroni L, (2002) Core binding factor genes and human leukemia. Haematologica 87: 1307-23.
43. Martens JH, (2011) Acute myeloid leukemia: a central role for the ets factor erg. Int J Biochem Cell Biol 43: 1413-6.
44. Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, et al. (2003) Aml with 11q23/mll abnormalities as defined by the who classification: incidence, partner chromosomes, fab subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed aml cases. Blood 102: 2395-2402.
45. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, et al. (1983) Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. a unique cytogenetic-clinicopathological association. N Engl J Med 309: 630-636.
46. Schoch C, Haase D, Haferlach T, Freund M, Link H, et al. (1996) Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients. British Journal of Haematology 94: 493-500.
47. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A, (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558-561.
48. Nucifora G, Larson RA, Rowley JD, (1993) Persistence of the 8;21 translocation in patients with acute myeloid leukemia type m2 in long-term remission. Blood 82: 712-715.
49. Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, et al. (2005) Evidence for reduced b-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 106: 2982-91.
50. Nolte F, Hofmann WK, (2010) Molecular mechanisms involved in the progression of myelodysplastic syndrome. Future Oncol 6: 445-55.
51. Valent P, Wieser R, (2009) Update on genetic and molecular markers associated with myelodysplastic syndromes. Leuk Lymphoma 50: 341-8.
52. Nikpour M, Pellagatti A, Liu A, Karimi M, Malcovati L, et al. (2010) Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (rars) and effects of g-csf. Br J Haematol 149: 844-54.
53. Ebert BL, Galili N, Tamayo P, Bosco J, Mak R, et al. (2008) An erythroid differentiation signature 1 predicts response to lenalidomide in myelodysplastic syndrome. PLoS Med 5: e35.
54. Visvader JE, (2011) Cells of origin in cancer. Nature 469: 314-22.
55. Lane SW, Scadden DT, Gilliland DG, (2009) The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 114: 1150-7.
56. Palmer MW, (1993) Putting things in even better order: The advantages of canonical correspondence analysis. Ecology 74: 2215-2230.
57. Ramette A, (2007) Multivariate analyses in microbial ecology. FEMS Microbiology Ecology 62: 142-160.
58. Sugiman T, (1998) Group dynamics in japan. Asian Journal of Social Psychology 1: 51-74.
59. ter Braak C, (1986) Canonical correspondence analysis: a new eigenvector technique for multivariate direct gradient analysis. Ecology 67: 1167-1179.
60. Kuhn A, Luthi-Carter R, Delorenzi M, (2008) Cross-species and cross-platform gene expression studies with the bioconductor-compliant r package 'annotationtools'. BMC Bioinformatics 9: 26.
61. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical bayes methods. Biostatistics 8: 118-27.
62. Oksanen J, Blanchet FG, Kindt R, Legendre P, O'Hara RG, et al. (2011) vegan: Community ecology package. Technical report. R package version 2.0-2.
63. McCune B, (1997) Inuence of noisy environmental data on canonical correspondence analysis. Ecology 78: 2617-2623.
64. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3.